Stock listing
603669 Stock Price, News, Filings & Events — Lionco Pharmaceutical Group Co., Ltd. Class A
Selected listing: 603669 · SSE · CNY · CN
603669:SSE is the primary listing for Lionco Pharmaceutical Group Co., Ltd. Class A, a public company based in China with a market capitalization of approximately 555.55 million USD. The company is dedicated to the pharmaceutical sector, working on innovations that enhance healthcare in the region. Recent developments and market activities reflect its commitment to advancing medical solutions and responding to industry needs. Investors can stay informed through the latest news, filings, and events related to the company.

- Ticker
- 603669:SSE
- Asset type
- Stock
- Market cap
- $531.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- SSE
- Currency
- CNY
Lionco Pharmaceutical Group Co., Ltd. Class A 603669:SSE stock context
603669:SSE is the primary listing for Lionco Pharmaceutical Group Co., Ltd. Class A, a public company based in China with a market capitalization of approximately 555.55 million USD. The company is dedicated to the pharmaceutical sector, working on innovations that enhance healthcare in the region. Recent developments and market activities reflect its commitment to advancing medical solutions and responding to industry needs. Investors can stay informed through the latest news, filings, and events related to the company.
Research Lionco Pharmaceutical Group Co., Ltd. Class A
Lionco Pharmaceutical Group Co., Ltd. Class A investor report
Review AI stock analysis and investor report context for 603669:SSE.
Lionco Pharmaceutical Group Co., Ltd. Class A company profile
View the public company page for Lionco Pharmaceutical Group Co., Ltd. Class A on 6ix.
Lionco Pharmaceutical Group Co., Ltd. Class A news
Read company news and market updates connected to Lionco Pharmaceutical Group Co., Ltd. Class A.
Lionco Pharmaceutical Group Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Lionco Pharmaceutical Group Co., Ltd. Class A.